We are live on ! Find out more
BHC icon

Bausch Health

454 hedge funds and large institutions have $38.7B invested in Bausch Health in 2014 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 163 increasing their positions, 162 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more funds holding in top 10

Funds holding in top 10: 6067 (+7)

1% more call options, than puts

Call options by funds: $1.39B | Put options by funds: $1.37B

1% more capital invested

Capital invested by funds: $38.3B → $38.7B (+$425M)

1% more repeat investments, than reductions

Existing positions increased: 163 | Existing positions reduced: 162

2.25% less ownership

Funds ownership: 90.34%88.09% (-2.2%)

4% less funds holding

Funds holding: 475454 (-21)

28% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 75

Holders
454
Holders Change
-21
Holders Change %
-4.42%
% of All Funds
13.17%
Holding in Top 10
67
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+11.67%
% of All Funds
1.94%
New
54
Increased
163
Reduced
162
Closed
75
Calls
$1.39B
Puts
$1.37B
Net Calls
+$17.9M
Net Calls Change
-$73.3M
Name Holding Trade Value Shares
Change
Change in
Stake
PIC
76
PCJ Investment Counsel
Ontario, Canada
$92.7M -$15.1M -126,929 -15%
BWCA
77
Brenner West Capital Advisors
New York
$88.3M -$22.9M -192,000 -22%
TCIM
78
TIAA CREF Investment Management
New York
$87.9M -$22.7M -190,068 -22%
AA
79
Antipodean Advisors
New York
$85.1M -$61.6M -516,639 -44%
EC
80
Eminence Capital
New York
$83.7M -$13.7M -115,004 -15%
Canada Pension Plan Investment Board
81
Canada Pension Plan Investment Board
Ontario, Canada
$83.6M +$2.24M +18,783 +3%
TCM
82
Tetrem Capital Management
Manitoba, Canada
$82.3M +$6.56M +55,032 +11%
SFM
83
Soros Fund Management
New York
$82.2M +$18.4M +154,561 +33%
TAL
84
TIG Advisors LLC
New York
$79.8M +$7.85M +65,854 +12%
CS
85
Credit Suisse
Switzerland
$78.9M +$64.6K +542 +0.1%
ACM
86
American Capital Management
New York
$78.1M -$83.4K -700 -0.1%
RCM
87
Roystone Capital Management
New York
$73M -$12.1M -101,160 -15%
Wells Fargo
88
Wells Fargo
California
$69M +$8.25M +69,227 +15%
PC
89
Paulson & Co
New York
$68.3M +$2.43M +20,400 +4%
U
90
UBS
Switzerland
$68M +$10.5M +87,813 +20%
Susquehanna International Group
91
Susquehanna International Group
Pennsylvania
$67.2M +$46.6M +390,615 +321%
Allianz Asset Management
92
Allianz Asset Management
Germany
$67.1M -$1.18M -9,919 -2%
MAA
93
Managed Account Advisors
New Jersey
$66M +$48.6K +408 +0.1%
NTC
94
North Tide Capital
Massachusetts
$65.6M
TI
95
Tyrian Investments
New York
$62.8M
RCM
96
Ratan Capital Management
Florida
$61.5M -$31.4M -263,589 -36%
TCA
97
Taconic Capital Advisors
New York
$59M -$47.7M -400,000 -47%
Bank of New York Mellon
98
Bank of New York Mellon
New York
$57.3M +$52M +436,476 New
FCM
99
Farallon Capital Management
California
$57.1M +$10.1M +85,000 +24%
IIM
100
Ivory Investment Management
New York
$56.4M +$4.41M +36,966 +9%

BHC Hedge Fund Activity: Q3 2014 in Review

454 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2014, worth a combined $38.7B — up 1.1% from $38.3B a quarter earlier.

Sellers outnumbered buyers: 75 funds closed out of BHC and 54 opened new positions — a net loss of 21 holders — while 162 trimmed existing stakes and 163 added.

The largest buyer was Fir Tree Capital Management, opening a new position worth an estimated $158M. The largest seller was Fidelity Investments, cutting an estimated $402M.

  • 454 institutional investors held Bausch Health (BHC) as of Q3 2014, down from 475 in Q2 2014.
  • Funds reported $38.7B of Bausch Health stock for Q3 2014, up 1.1% quarter-over-quarter.
  • 54 funds opened new Bausch Health positions in Q3 2014 and 75 closed out, a net change of -21 holders.
  • The largest Bausch Health buyer in Q3 2014 was Fir Tree Capital Management, an estimated $158M added.
  • The largest Bausch Health seller in Q3 2014 was Fidelity Investments, an estimated $402M sold.

Based on aggregated 13F filings for Q3 2014.